CORESTA Meeting, Smoke Science/Product Technology, 2015, Jeju, STPOST 05
Quantitative screening of potential contaminants in e-cigarette formulations: ethylene glycol and diethylene glycol
Altria Client Services, Richmond, VA, U.S.A.
The U.S. Food and Drug Administration (FDA) evaluated two commercial e-cigarettes and a nicotine replacement therapy inhaler in 2009 (DPATR-FY-09-23). Ethylene glycol (EG) and diethylene glycol (DEG) were included in this evaluation as potential...